CARLIER, Jeremy
 Distribuzione geografica
Continente #
NA - Nord America 6.345
AS - Asia 1.903
EU - Europa 1.764
SA - Sud America 324
Continente sconosciuto - Info sul continente non disponibili 188
AF - Africa 131
OC - Oceania 13
Totale 10.668
Nazione #
US - Stati Uniti d'America 6.129
IT - Italia 617
SG - Singapore 560
CN - Cina 335
VN - Vietnam 329
RU - Federazione Russa 282
HK - Hong Kong 246
BR - Brasile 233
IE - Irlanda 131
SE - Svezia 125
GB - Regno Unito 123
CA - Canada 114
DE - Germania 114
FR - Francia 109
BD - Bangladesh 97
IN - India 87
NL - Olanda 59
MX - Messico 47
CI - Costa d'Avorio 42
FI - Finlandia 37
JP - Giappone 37
PL - Polonia 27
AR - Argentina 26
IQ - Iraq 25
TR - Turchia 25
BE - Belgio 23
ID - Indonesia 23
ES - Italia 20
ZA - Sudafrica 19
KR - Corea 17
LT - Lituania 17
PK - Pakistan 17
AT - Austria 16
MA - Marocco 16
EC - Ecuador 15
IL - Israele 14
PH - Filippine 14
CO - Colombia 12
TH - Thailandia 12
UA - Ucraina 12
VE - Venezuela 12
KE - Kenya 11
RO - Romania 11
EG - Egitto 10
AU - Australia 9
CL - Cile 9
CR - Costa Rica 8
GR - Grecia 8
IR - Iran 8
SA - Arabia Saudita 8
SV - El Salvador 8
TW - Taiwan 8
GP - Guadalupe 7
JM - Giamaica 7
JO - Giordania 7
TN - Tunisia 7
AE - Emirati Arabi Uniti 6
CW - ???statistics.table.value.countryCode.CW??? 6
DZ - Algeria 6
NG - Nigeria 6
NI - Nicaragua 6
CH - Svizzera 5
GH - Ghana 5
PE - Perù 5
MY - Malesia 4
NZ - Nuova Zelanda 4
OM - Oman 4
PT - Portogallo 4
TT - Trinidad e Tobago 4
UY - Uruguay 4
BY - Bielorussia 3
CZ - Repubblica Ceca 3
GT - Guatemala 3
GY - Guiana 3
HN - Honduras 3
MD - Moldavia 3
PR - Porto Rico 3
PY - Paraguay 3
UZ - Uzbekistan 3
AL - Albania 2
BO - Bolivia 2
ET - Etiopia 2
HT - Haiti 2
KH - Cambogia 2
MK - Macedonia 2
ML - Mali 2
NP - Nepal 2
PS - Palestinian Territory 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
AM - Armenia 1
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EU - Europa 1
Totale 10.469
Città #
Ashburn 1.246
Dallas 658
Singapore 312
San Jose 285
Chandler 283
Hong Kong 231
Los Angeles 183
Council Bluffs 174
New York 149
Dublin 125
The Dalles 114
Boardman 109
Des Moines 106
Ho Chi Minh City 105
Beijing 103
Hanoi 76
Fairfield 75
Santa Clara 67
Lauterbourg 63
Phoenix 63
Denver 62
San Francisco 60
Chicago 52
Milan 51
Rome 51
Moscow 50
Atlanta 48
Ancona 47
Orem 47
Seattle 44
Abidjan 42
Montreal 41
Lawrence 40
Princeton 40
Houston 36
London 34
Munich 34
Irvington 31
São Paulo 31
Turin 31
Brooklyn 30
Washington 29
Tokyo 28
Woodbridge 27
Buffalo 26
Cambridge 24
Warsaw 24
Jacksonville 23
Boston 21
Brussels 19
Frankfurt am Main 19
Helsinki 19
Columbus 18
Hefei 18
Wilmington 18
Da Nang 17
Turku 17
Chennai 16
Toronto 16
Haiphong 15
Mexico City 15
San Diego 14
Amsterdam 13
Naples 13
Shanghai 13
Tolentino 13
Poplar 12
Baghdad 11
Salt Lake City 11
San Mateo 11
Shenzhen 11
Manchester 10
Nairobi 10
Vienna 10
Vilnius 10
Johannesburg 9
Nuremberg 9
Pune 9
Rancho Palos Verdes 9
Stockholm 9
Ann Arbor 8
Athens 8
Elk Grove Village 8
Querétaro 8
Raleigh 8
Verona 8
Amman 7
Ankara 7
Bologna 7
Boydton 7
Detroit 7
Guangzhou 7
Palermo 7
Quito 7
San José 7
Augusta 6
Birmingham 6
City of London 6
Goiânia 6
Madrid 6
Totale 6.186
Nome #
UHPLC-MS-MS Determination of THC, CBD and Their Metabolites in Whole Blood of Light Cannabis Smokers 1.012
Quantification of pregabalin using hydrophilic interaction hplc-high-resolution ms in postmortem human samples: Eighteen case reports 391
Protodioscin, a natural saponin with potential steroidogenic effects: metabolic and analytical considerations 335
Chlorthalidone In Vitro Metabolite Identification for Documenting Exposure in Doping 315
Pharmacology of herbal sexual enhancers: A review of psychiatric and neurological adverse effects 256
Human diagnostic markers for intake of semi-synthetic cannabinoids (9R)- and (9S)-hexahydrocannabinol 251
Human metabolism and pharmacological profiling of protonitazepyne and metonitazepyne, two highly potent nitazenes: prediction of main metabolite activity based on µ-opioid receptor docking simulations 238
Drug-facilitated sexual assaults (DFSA): A serious underestimated issue 223
In silico and in vitro human metabolism of IOX2, a performance-enhancing doping agent 202
New challenges in clinical and forensic toxicology 192
Human metabolism of four synthetic benzimidazole opioids: isotonitazene, metonitazene, etodesnitazene, and metodesnitazene 188
3-CMC, 4-CMC, and 4-BMC Human Metabolic Profiling: New Major Pathways to Document Consumption of Methcathinone Analogues? 185
“Tranq-dope”: The first fatal intoxication due to xylazine-adulterated heroin in Italy 184
Acute Intoxications and Fatalities Associated with Benzimidazole Opioid (Nitazene Analog) Use: A Systematic Review 183
Disposition of Hexahydrocannabinol Epimers and Their Metabolites in Biological Matrices following a Single Administration of Smoked Hexahydrocannabinol: A Preliminary Study 179
Dipyanone, a new methadone-like synthetic opioid: In vitro and in vivo human metabolism and pharmacological profiling 170
The principal toxic glycosidic steroids in Cerbera manghas L. seeds: Identification of cerberin, neriifolin, tanghinin and deacetyltanghinin by UHPLC-HRMS/MS, quantification by UHPLC-PDA-MS 166
In silico prediction, LC-HRMS/MS analysis, and targeted/untargeted data-mining workflow for the profiling of phenylfentanyl in vitro metabolites 165
Monitoring Prenatal Exposure to Buprenorphine and Methadone 157
In vitro, in vivo metabolism and quantification of the novel synthetic opioid N-piperidinyl etonitazene (etonitazepipne) 154
A 2017-2019 Update on Acute Intoxications and Fatalities from Illicit Fentanyl and Analogs 154
Exploring the Metabolism of Flubrotizolam, a Potent Thieno-Triazolo Diazepine, Using Human Hepatocytes and High-Resolution Mass Spectrometry 153
β'-Phenylfentanyl Metabolism in Primary Human Hepatocyte Incubations: Identification of Potential Biomarkers of Exposure in Clinical and Forensic Toxicology 151
In Vitro and In Vivo Human Metabolism of Ostarine, a Selective Androgen Receptor Modulator and Doping Agent 151
QuEChERS Extraction and Simultaneous Quantification in GC-MS/MS of Hexahydrocannabinol Epimers and Their Metabolites in Whole Blood, Urine, and Oral Fluid 145
Use of cognitive enhancers: Methylphenidate and analogs 145
Pyrrolidinyl synthetic cathinones α-php and 4f-α-pvp metabolite profiling using human hepatocyte incubations 145
3F-α-pyrrolydinovalerophenone (3F-α-PVP) in vitro human metabolism: Multiple in silico predictions to assist in LC-HRMS/MS analysis and targeted/untargeted data mining 141
Testing Unconventional Matrices to Monitor for Prenatal Exposure to Heroin, Cocaine, Amphetamines, Synthetic Cathinones, and Synthetic Opioids 140
Consequences of COVID-19 Lockdown on the Misuse and Marketing of Addictive Substances and New Psychoactive Substances 137
Biomarkers of 4-hydroxy-N,N-methylpropyltryptamine (4-OH-MPT) intake identified from human hepatocyte incubations 136
Ultra-high-performance liquid chromatography-tandem mass spectrometry assay for quantifying fentanyl and 22 analogs and metabolites in whole blood, urine, and hair 134
Advances in forensic toxicology 128
Cannabidiol adverse effects and toxicity 126
Distinguishing intake of new synthetic cannabinoids ADB-PINACA and 5F-ADB-PINACA with human hepatocyte metabolites and high-resolution mass spectrometry 126
Development of an enantioselective high-performance liquid chromatography-tandem mass spectrometry method for the quantitative determination of methorphan and its O-demethylated metabolite in human blood and its application to post-mortem samples 124
Monitoring Perinatal Exposure to Cannabis and Synthetic Cannabinoids 123
Quantification of Carbonic Anhydrase Inhibitors and Metabolites in Urine and Hair of Patients and Their Relatives 122
Metabolism Study of Anamorelin, a GHSR1a Receptor Agonist Potentially Misused in Sport, with Human Hepatocytes and LC-HRMS/MS 121
Measurement uncertainty in forensic toxicology 116
In silico, in vitro, and in vivo human metabolism of acetazolamide, a carbonic anhydrase inhibitor and common “diuretic and masking agent” in doping 111
Fatal intoxication after taking iboga: GC-MS/MS determination of ibogaine and ibogamine in iboga roots and post-mortem material 110
In vivo and in vitro metabolism of the designer benzodiazepine, bretazenil: a comparison of pooled human hepatocytes and liver microsomes with postmortem urine and blood samples 107
Fatal intoxication due to ackee (Blighia sapida) in Suriname and French Guyana. GC-MS detection and quantification of hypoglycin-A 107
Synthetic cannabinoid BB-22 (QUCHIC): Human hepatocytes metabolism with liquid chromatography-high resolution mass spectrometry detection 105
Metabolism and detection of designer benzodiazepines: a systematic review 104
A validated method for quantifying hypoglycin A in whole blood by UHPLC-HRMS/MS 104
Identification of alexamorelin consumption biomarkers using human hepatocyte incubations and high-resolution mass spectrometry 103
Atropine eye drops: An unusual homicidal poisoning 100
In vitro and in vivo human metabolism of a new synthetic cannabinoid NM-2201 (CBL-2201) 97
In vitro metabolite profiling of ADB-FUBINACA, a new synthetic cannabinoid 97
Identification of New Synthetic Cannabinoid ADB-CHMINACA (MAB-CHMINACA) Metabolites in Human Hepatocytes 97
Update on Cannabidiol Clinical Toxicity and Adverse Effects: a Systematic Review 96
Pharmacodynamic effects, pharmacokinetics, and metabolism of the synthetic cannabinoid AM-2201 in male rats 96
Comparison of authentic urine N-ethylpentedrone metabolites to predicted in silico and in vitro human hepatocyte metabolism 95
α-Methyltryptamine (α-MT) Metabolite Profiling in Human Hepatocyte Incubations and Postmortem Urine and Blood 94
25C-NBOMe and 25I-NBOMe metabolite studies in human hepatocytes, in vivo mouse and human urine with high-resolution mass spectrometry 94
A validated method for quantifying atractyloside and carboxyatractyloside in blood by hplc-hrms/ms, a non-fatal case of intoxication with atractylis gummifera l 94
Human Hepatocyte 4-Acetoxy-N,N-Diisopropyltryptamine Metabolite Profiling by Reversed-Phase Liquid Chromatography Coupled with High-Resolution Tandem Mass Spectrometry 93
Insights into the human metabolism and in silico receptor activity of gidazepam and desalkylgidazepam 85
Fatal case of a 27-year-old male after taking iboga in withdrawal treatment: GC-MS/MS determination of ibogaine and ibogamine in iboga roots and postmortem biological material 85
Human hepatocyte metabolism of novel synthetic cannabinoids MN-18 and its 5-fluoro analog 5F-MN-18 85
Screening approach by ultra-high performance liquid chromatography-tandem mass spectrometry for the blood quantification of thirty-four toxic principles of plant origin. Application to forensic toxicology 82
Quantification of [1-(5-fluoropentyl)-1H-indol-3-yl](naphthalene-1-yl)methanone (AM-2201) and 13 metabolites in human and rat plasma by liquid chromatography-tandem mass spectrometry 80
In vitro, in vivo and in silico metabolic profiling of α-pyrrolidinopentiothiophenone, a novel thiophene stimulant 72
In Vitro Metabolism of a Benzofuran-Substituted Nitazene: Ethyleneoxynitazene 66
In vitro metabolism of new synthetic cannabinoid SDB-006 in human hepatocytes by high-resolution mass spectrometry 66
Metabolism of the new synthetic cannabinoid EG-018 in human hepatocytes by high-resolution mass spectrometry 66
Synthetic cannabinoids: Analytical methods 63
Quantification of hypoglycin A in serum using aTRAQ® assay 53
Structure-activity relationship of prevalent synthetic cannabinoid metabolites on hCB1 in vitro and in silico dynamics 49
Synthetic cannabinoid receptor agonists containing silicon: exploring the metabolic pathways of ADMB- and Cumyl-3TMS-PrINACA in human urine specimens and post mortem material compared to in vitro and in silico data 48
Totale 10.668
Categoria #
all - tutte 41.355
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.355


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022215 0 0 0 0 1 15 4 7 14 18 94 62
2022/2023824 57 95 49 77 51 182 2 54 178 7 46 26
2023/2024543 65 19 78 75 91 83 17 15 4 21 24 51
2024/20251.376 101 93 26 49 78 73 164 64 206 149 197 176
2025/20264.698 269 584 287 397 449 226 831 398 379 394 243 241
2026/20272.793 584 1.085 501 607 16 0 0 0 0 0 0 0
Totale 10.668